Skip to content

Clinical trials

Phase 4 Diabetes Mellitus, Type 2 trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 4 Country / region: Sweden Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20042
20051
20062
20073
20082
20094
20102
20122
20131
20142
20152
20163
20171
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lund University6
Karolinska Institutet5
Sanofi5
AstraZeneca4
Novo Nordisk A/S4
GlaxoSmithKline3
Uppsala University2
Janssen Research & Development, LLC1
Pfizer1
Skane University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 232
Diabetes Mellitus7
Insulin Resistance3
Glucose Intolerance2
Albuminuria1
Angina, Unstable1
Hyperglycemia1
Hypoglycemia1
Myocardial Infarction1
Vitamin D Deficiency1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.